(AGENPARL) – BARCELONA mer 21 giugno 2023
Nuage Therapeutics raises €12M in Seed Financing led by Sofinnova Partners and Asabys
EnzoAndres.Crisosto
Wed, 06/21/2023 – 08:33
Nuage Therapeutics (“Nuage”), a biotech company developing a drug discovery engine for small molecule modulators of intrinsically disordered proteins (IDPs), announces today the successful closing of a €12 million Seed financing to support the development of its lead program and validate its pioneering drug discovery platform.
Fonte/Source: https://www.irbbarcelona.org/en/news/institutional/nuage-therapeutics-raises-eu12m-seed-financing-led-sofinnova-partners-and-asabys